Merit Medical Systems is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. The company was founded in 1987 and is based in South Jordan, Utah.
MMSI Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Merit Medical Systems Inc. To summarize, we found that Merit Medical Systems Inc ranked in the 37th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for MMSI, they are:
Merit Medical Systems Inc's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 71.21% of tickers in our DCF set.
Merit Medical Systems Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -2.08. This coverage rate is greater than that of just 17.39% of stocks we're observing for the purpose of forecasting via discounted cash flows.
As a business, Merit Medical Systems Inc experienced a tax rate of about 18% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than 77.68% of stocks generating free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
CRL, PKI, IART, MGLN, and ITGR can be thought of as valuation peers to MMSI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
ReportsnReports.com the exclusive leading provider of market research reports published research report on “Global Interventional Cardiovascular Device Market Research Report 2021”. The Global Interventional Cardiovascular Device Market Report 2021 is a professional and in-depth study on the current state of the
DUBLIN--(BUSINESS WIRE)--The "Angioplasty Balloons Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The rise in the geriatric population could result in an exponential increase in Coronary heart disease prevalence, which, in turn, is propelling the angioplasty balloons market. Companies Mentioned Abbot Laboratories AngioDynamics BIOTRONIK Boston Scientific Corporation Cook Medical Cordis (Cardinal Health) Medtronic Merit Medical S